ATE424188T1 - Isotone fettemulsionen - Google Patents

Isotone fettemulsionen

Info

Publication number
ATE424188T1
ATE424188T1 AT02748862T AT02748862T ATE424188T1 AT E424188 T1 ATE424188 T1 AT E424188T1 AT 02748862 T AT02748862 T AT 02748862T AT 02748862 T AT02748862 T AT 02748862T AT E424188 T1 ATE424188 T1 AT E424188T1
Authority
AT
Austria
Prior art keywords
isotone
fat emulsions
organs
tissues
cell membranes
Prior art date
Application number
AT02748862T
Other languages
English (en)
Inventor
Yvon Carpentier
Isabelle Dupont
Original Assignee
Target Hit Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Target Hit Sa filed Critical Target Hit Sa
Application granted granted Critical
Publication of ATE424188T1 publication Critical patent/ATE424188T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02748862T 2001-07-25 2002-07-20 Isotone fettemulsionen ATE424188T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01117991A EP1279400A1 (de) 2001-07-25 2001-07-25 Änderung der Fettsäurezusammensetzung Organ- und Gewebe-Zellmembranen

Publications (1)

Publication Number Publication Date
ATE424188T1 true ATE424188T1 (de) 2009-03-15

Family

ID=8178132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748862T ATE424188T1 (de) 2001-07-25 2002-07-20 Isotone fettemulsionen

Country Status (10)

Country Link
US (1) US7560486B2 (de)
EP (2) EP1279400A1 (de)
JP (1) JP2005501828A (de)
CN (1) CN1267085C (de)
AT (1) ATE424188T1 (de)
CA (1) CA2454665C (de)
DE (1) DE60231406D1 (de)
ES (1) ES2324526T3 (de)
IL (1) IL160012A0 (de)
WO (1) WO2003009828A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
US20070149617A1 (en) 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
PE20070999A1 (es) * 2005-12-09 2007-09-28 Drugtech Corp Emulsion de acido graso esencial intravenosa
DK1800675T3 (da) 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
WO2008147562A2 (en) * 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
US20090117253A1 (en) 2007-10-03 2009-05-07 E. I. Du Pont De Nemours And Company Peroxisome biogenesis factor protein (pex) disruptions for altering polyunsaturated fatty acids and total lipid content in oleaginous eukaryotic organisms
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) * 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
JP5498491B2 (ja) 2008-07-07 2014-05-21 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその栄養組成物の使用方法
WO2010119319A1 (en) 2009-03-09 2010-10-21 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
BR112012016435A2 (pt) 2010-01-04 2019-09-24 Pentec Health Inc método para tratar desnutrição em um paciente de hemodiálise e composição aquosa estéril para administração parenteral
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
CN103747674B (zh) 2011-06-09 2016-06-15 生命线科学有限公司 器官/组织的活力的评价、维持和/或恢复
WO2013031729A1 (ja) * 2011-08-26 2013-03-07 国立大学法人大阪大学 糖尿病性心血管合併症の予防・治療剤
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
EP2958559A4 (de) * 2013-02-20 2016-07-20 Univ Columbia Verwendung einer omega-3-emulsion auf lipidbasis zum schutz von organen vor ischämischer läsion
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
EP2978307B1 (de) 2013-03-28 2018-12-26 The Trustees of Columbia University in the City of New York Reperfusion mit omega-3-glyceriden zur förderung eines spenderorganschutzes für transplantationen
US10597314B2 (en) 2013-11-22 2020-03-24 General Electric Company Fatty acid biodispersant and methods of use
EP3191091B1 (de) * 2014-09-12 2020-08-26 Children's Medical Center Corporation Formulierungen einer diätetischen emulsion und verfahren zur verwendung davon
CN106667910B (zh) * 2017-01-12 2021-02-02 西南大学 一种谷维素鱼油纳米乳液及其制备方法和应用
PT3664628T (pt) * 2017-08-10 2024-12-31 Childrens Medical Ct Corp Métodos e composições relacionados com emulsões compreendendo óleo de peixe e/ou ácidos gordos ómega-3
EP4181876A1 (de) * 2020-07-14 2023-05-24 Nutrition Lipid Developments Isotonische lipidemulsion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049747A (ja) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk リン脂質組成物
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
DE3903057A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
DE3903056A1 (de) 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
CN1259908C (zh) 1995-11-28 2006-06-21 B·布朗·梅尔松根有限公司 最优化水解的脂质乳剂及其用途

Also Published As

Publication number Publication date
CA2454665A1 (en) 2003-02-06
ES2324526T3 (es) 2009-08-10
IL160012A0 (en) 2004-06-20
JP2005501828A (ja) 2005-01-20
US20040247693A1 (en) 2004-12-09
CN1553798A (zh) 2004-12-08
CA2454665C (en) 2011-10-11
US7560486B2 (en) 2009-07-14
CN1267085C (zh) 2006-08-02
EP1408931A1 (de) 2004-04-21
DE60231406D1 (de) 2009-04-16
EP1408931B1 (de) 2009-03-04
WO2003009828A1 (en) 2003-02-06
EP1279400A1 (de) 2003-01-29

Similar Documents

Publication Publication Date Title
ATE424188T1 (de) Isotone fettemulsionen
DE60114606D1 (de) Ausgewogene lipidzusammensetzung enthaltende eier
EP1537069A4 (de) ANALOGA VON OMEGA-3-PUFAs ABGELEITETEN LIPIDMEDIATOREN UND ANWENDUNGSVERFAHREN
WO2008005869A3 (en) Infant formulas for early brain development
ATE549014T1 (de) Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel
BR0110664A (pt) Composição de gordura alimentìcia escoável, e, uso de uma combinação de um éster de ácido cìtrico de glicerìdeos parciais de ácido graxo e um sal
ATE446123T1 (de) Lipidpräparat zur verbesserung der mineralabsorption
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
ATE297974T1 (de) Verfahren zur reinigung von an omega-3-fettsäuren angereichertem meeressäugetieröl und dessen zusammensetzungen
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
de Wilde et al. Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
BR0309089A (pt) Métodos dietéticos para melhoria de desempenho em cães
DE60218481D1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
PE20070999A1 (es) Emulsion de acido graso esencial intravenosa
NO20024722L (no) Stivelses-subtyper og lipid metabolisme
DE59002572D1 (de) Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung.
DE60226257D1 (de) Schäumende emulsionen des öl-in-wasser-typs und verfahren zu ihrer herstellung
DK0790056T3 (da) Anvendelse af præparat til forebyggelse eller behandling af sygdomme forårsaget af abnormiteter i bruskvæv
TW200612834A (en) Acidic oil-in-water emulsion composition
Zimmer et al. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex
FI980961A0 (fi) Menetelmä märehtijän maito- ja/tai kudosrasvan konjugoidun linolihaponpitoisuuden nostamiseksi
RU2052947C1 (ru) Масложировой продукт, имеющий иммуностимулирующие свойства
ES2325380T3 (es) Composicion cosmetica que comprende una fraccion lipida procedente de fuente vegetal y agente anticristalizante.
RU2006105335A (ru) Mvl-косметика

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1408931

Country of ref document: EP